Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | TSC2 |
Variant | L1137F |
Impact List | missense |
Protein Effect | unknown |
Gene Variant Descriptions | TSC2 L1137F does not lie within any known functional domains of the Tsc2 protein (UniProt.org). L1137F has not been characterized and therefore, its effect on Tsc2 protein function is unknown (PubMed, Sep 2024). |
Associated Drug Resistance | |
Category Variants Paths |
TSC2 mutant TSC2 L1137F |
Transcript | NM_000548.5 |
gDNA | chr16:g.2080176C>T |
cDNA | c.3409C>T |
Protein | p.L1137F |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001114382 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
XM_011522636.2 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
NM_001114382.3 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
XM_011522638 | chr16:g.2079391_2079393delCTGinsTTT | c.3409_3411delCTGinsTTT | p.L1137F | RefSeq | GRCh38/hg38 |
NM_001406667.1 | chr16:g.2080215_2080217delCTGinsTTT | c.3409_3411delCTGinsTTT | p.L1137F | RefSeq | GRCh38/hg38 |
NM_000548.5 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
XM_011522636 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
XM_011522638.2 | chr16:g.2079391_2079393delCTGinsTTT | c.3409_3411delCTGinsTTT | p.L1137F | RefSeq | GRCh38/hg38 |
NM_000548.4 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
NM_001114382.2 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
XM_011522636.3 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
NM_000548 | chr16:g.2080176C>T | c.3409C>T | p.L1137F | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|